Fluair Inhaler

Introduction

Fluticasone Propionate is a corticosteroid used in inhaler form to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It works by reducing inflammation in the airways, thereby easing breathing and improving respiratory function.

Uses

Fluticasone Propionate inhalers are used to:

Control and prevent asthma symptoms such as wheezing, shortness of breath, and coughing.
Manage chronic symptoms of COPD and improve lung function.
Reduce the frequency of asthma attacks and exacerbations in chronic respiratory conditions.

Brand Name	Fluair
Type	Inhaler
Weight	250 mcg/metered dose
Generic	Fluticasone Propionate (Inhaler)
Manufacturer	UniMed UniHealth Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Fluticasone Propionate works by binding to glucocorticoid receptors in the lungs, leading to decreased synthesis of inflammatory mediators. This results in reduced inflammation, swelling, and mucus production in the airways, which helps in improving airflow and reducing respiratory symptoms.

How Long Does It Take to Work?

Fluticasone Propionate may take several days to weeks of regular use to achieve its full effect. Improvement in asthma symptoms or COPD management may be noticeable within 1-2 weeks, but optimal control is often seen after 4-6 weeks of consistent use.

Absorption

When inhaled, Fluticasone Propionate is absorbed into the lungs and has minimal systemic absorption. A small amount of the drug may be absorbed into the bloodstream via the respiratory tract, but it is mostly localized in the lungs where it exerts its therapeutic effects.

Route of Elimination

Fluticasone Propionate is primarily eliminated through hepatic metabolism. The drug is metabolized in the liver and then excreted in the feces. A minor amount is excreted unchanged in the urine.

Dosage

Adults and children over 16 years of age: 100 to 1000 mcg twice daily. Patients should be given a starting dose of inhaled fluticasone propionate which is appropriate for the severity of their disease:

Mild asthma: 100 to 250 mcg twice daily; Moderate asthma: 250 to 500 mcg twice daily,

Severe asthma: 500 to 1000 mcg twice daily.

Children over 4 years of age: 50 to 200 mcg twice daily.

Children aged 1 to 4 years: 100 mcg twice daily administered via a paediatric spacer device with a face mask.

Special patient groups: There is no need to adjust the dose in elderly patients or in those with hepatic or renal impairment.

The typical dosage for Fluticasone Propionate inhalers is:

For asthma: 88-220 mcg twice daily, depending on the severity of the condition and the specific product used.
For COPD: 100-500 mcg twice daily, adjusted according to the individual’s response and clinical needs.

Dosage may vary based on the specific inhaler formulation and the patient's response. It is important to follow the dosage instructions provided by a healthcare provider or on the product label.

Administration

Fluticasone Propionate is administered via an inhaler. It is important to use the inhaler correctly to ensure proper delivery of the medication to the lungs. Patients should follow the instructions for use provided with the inhaler and rinse their mouth after use to prevent oral thrush.

Side Effects

Common side effects may include:

Oral thrush (fungal infection in the mouth).
Hoarseness or voice changes.
Dry mouth or throat irritation.
Cough.

Less common side effects may include systemic corticosteroid effects if used inappropriately at high doses.

Toxicity

Toxicity from Fluticasone Propionate is rare when used as directed. Overuse or misuse can lead to systemic side effects such as adrenal suppression, Cushing’s syndrome, or growth retardation in children. Seek medical attention if symptoms of overdose or severe side effects occur.

Precautions

Precautions include:

Monitor for signs of oral thrush and take preventive measures such as mouth rinsing after use.
Use with caution in patients with a history of tuberculosis or other infections.
Regularly check for potential side effects and adjust dosage as necessary under medical supervision.

Interaction

Drug interactions are minimal with Fluticasone Propionate, but it may interact with other corticosteroids or medications that affect liver enzyme activity. Always inform healthcare providers of all medications being taken to avoid potential interactions.

Disease Interaction

Use with caution in patients with:

Active or history of tuberculosis.
Uncontrolled diabetes.
Severe hepatic impairment, as it may affect drug metabolism.

Drug Interaction

Drug interactions may include:

Interactions with other corticosteroids or systemic drugs that may increase the risk of side effects.
Potential interactions with medications that affect hepatic enzyme activity, which may alter the metabolism of Fluticasone Propionate.

Food Interactions

Food interactions are minimal with Fluticasone Propionate. It can be taken with or without food. However, avoiding large meals immediately before or after using the inhaler may help prevent potential throat irritation.

Pregnancy Use

Fluticasone Propionate should be used during pregnancy only if the potential benefit justifies the risk to the fetus. Consult with a healthcare provider to evaluate the risks and benefits and to discuss alternative treatment options if necessary.

Lactation Use

Fluticasone Propionate is excreted in breast milk, but at low levels. It is generally considered safe to use while breastfeeding, but consult with a healthcare provider to assess any potential risks to the infant and to determine the best course of action.

Acute Overdose

Acute overdose of Fluticasone Propionate is unlikely but could potentially cause symptoms related to systemic corticosteroid effects. In case of overdose, discontinue use and seek medical advice immediately for appropriate management and monitoring.

Contraindication

Fluticasone Propionate is contraindicated in individuals with:

Hypersensitivity to fluticasone propionate or any component of the inhaler.
Active or untreated fungal, bacterial, or viral infections of the respiratory system.

Use Direction

Follow the instructions provided with the inhaler or as directed by a healthcare provider. Use the inhaler consistently at the prescribed dosage and frequency. Rinse your mouth after each use to minimize the risk of oral thrush. Do not exceed the recommended dose without medical advice.

Storage Conditions

Store the inhaler at room temperature, away from direct sunlight and moisture. Do not freeze. Keep out of reach of children and do not use the inhaler past its expiration date. Proper storage ensures the medication remains effective and safe to use.

Volume of Distribution

The volume of distribution for inhaled Fluticasone Propionate is not typically specified, as it primarily targets the lungs with minimal systemic distribution.

Half Life

The half-life of Fluticasone Propionate in the body is approximately 8 hours. However, the effects of the medication may last longer due to its anti-inflammatory properties and its impact on the respiratory system.

Clearance

Fluticasone Propionate is primarily cleared from the body through hepatic metabolism and subsequent fecal excretion. The clearance rate can be affected by liver function and other individual factors.

See in details version Fluair Inhaler 250 mcg/metered dose also Fluair Inhaler 250 mcg/metered dose in bangla